Rule 8.3 - Alltracel Pharmaceuticals Plc

    

Loeb Partners Corporation



FORM 8.1/8.3

IRISH TAKEOVER PANEL

Lodge with the Stock Exchange (which may publicise) and the Panel. Use separate
form for each class of securities in which dealings have been made.

Date of Disclosure: March 3, 2008


 DISCLOSURE UNDER RULE 8.1(a), 8.1(b)(i) and 8.3 OF THE IRISH TAKEOVER PANEL ACT

                          1997, TAKEOVER RULES, 2007


Date of Dealing: February 29, 2008


Dealing in: Alltracel Pharmaceuticals Plc


(1) Class of securities (e.g. ordinary shares) ordinary shares (via swap)


(2)

Amount bought                Amount sold                  Price per unit

125,000                                                    13 GBP


(3) Resultant total of the same class owned or controlled (and percentage of
class)

1,325,000       1.02%


(4) Party making disclosure

Loeb Holding Corporation


(5)  EITHER     (a)      Name of purchaser/vendor

     OR         (b)      If dealing for discretionary client(s), name of fund

                         management organisation


                       Loeb Holding Corporation


(6) Reason for disclosure

           (a)       (I)      offeror or associate of offeror                NO

                    (II)      offeree or associate of offeree                NO


        Specify which category or categories of associate ((a) to (l) page 3/4)


        If category (l) explain    



(b)    Rule 8.3 (i.e. disclosure because of ownership or control of 1% or more

       of the class of relevant securities dealt in)                        YES


Signed, for and on behalf of the party named in (4) above

Shelby Drescher


(Also print name of signatory)

Shelby Drescher


Telephone and extension number +1 212-483-7070

Alltracel Pharmaceuticals (LSE:AP.)
過去株価チャート
から 4 2024 まで 5 2024